According to the company, the SmoothShapes system uses a proprietary technology called Photomology that features an unique mechanism of action combining dynamic laser and light energy with mechanical
Most recently, Mr Elgin has served as vice president of business development and COO for Novaflux Technologies. Mr Elgin has earned his bachelor of arts degree from Queens
Ranaz has issued three million units at $0.60 per unit. Each unit comprises one share and half a warrant, with each whole warrant entitling its holder to purchase
The founder and the current CEO, Mohan Uttarwar will remain with the company, serve on the board of directors, and take on the role of chief strategy officer.
Three Rivers Pharmaceuticals will obtain commercial rights to Infergen in all markets except Japan. In addition, Three Rivers Pharmaceuticals will obtain commercial rights to China, effective March 31,
The trial has demonstrated a favorable safety profile with Vivecon in 55 subjects enrolled across nine cohorts. The Phase I trial was designed as a single ascending dose
The supplemental new drug application (sNDA) filing was based upon data from the pivotal registrational trial, which provided estimates of the probability of patients attaining blood pressure goals
The placement was anchored by a commitment of A$6.5 million by existing major shareholders Alta Partners, GBS Venture Partners and Merck Sante, a subsidiary of Merck KGaA. These
The novel devices to be developed by DSM Biomedical and Caliber Therapeutics will enable the controlled and sustained release of drugs to treat vascular diseases such as atherosclerosis.
As part of Genstruct’s executive management team, Mr Latino will lead the company’s global sales efforts, focusing on building the company’s sales infrastructure to drive future growth. In
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.